Abstract
Genomic instability has been a recognized feature of many human tumors for decades. Until recently, however, there was little insight into potential mechanisms for this phenomenon. Recent work has shown first, that increased centrosome numbers (also referred to as centrosome amplification) often accompany genomic instability and second, that when centrosome numbers are increased, cells become genetically unstable. Deletion of Gadd45a leads to centrosome amplification and consequent abnormal mitosis and aneuploidy. Gadd45a is known to be involved in a G2 checkpoint and may be involved in the normal progression from G2 to M and its coordination with S phase events. Whether these functions contribute to prevention of centrosome amplification is being investigated. However, potential mechanisms can be proposed based on known protein associations with Gadd45a, as well as proteins that regulate Gadd45a transcription and are also required for efficient coordination of centrosome duplication and DNA synthesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Amundson SA, Zhan Q, Penn LZ, Fornace Jr AJ . 1998 Oncogene 17: 2149–2154
Amundson SA, Myers TG, Scudiero D, Kitada S, Reed JC, Fornace Jr AJ . 2000 Cancer Res. 60: 6101–6110
Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y . 1998 Science 281: 1674–1677
Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D, Wynshaw-Boris A . 1996 Cell 86: 159–171
Baumer M, Kunzler M, Steigemann P, Braus GH, Irniger S . 2000 J. Biol. Chem. 275: 38929–38937
Bertwistle D, Ashworth A . 1999 Breast Cancer Res. 1: 41–47
Blangy A, Lane HA, d'Herin P, Harper M, Kress M, Nigg EA . 1995 Cell 83: 1159–1169
Boxer LM, Dang CV . 2001 Oncogene 20: 5595–5610
Bush A, Mateyak M, Dugan K, Obaya A, Adachi S, Sedivy J, Cole M . 1998 Genes Dev. 12: 3797–3802
Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A . 2002 Science 296: 922–927
Clarke DJ, Segal M, Mondesert G, Reed SI . 1999 Curr. Biol. 9: 365–368
Clarke DJ, Segal M, Jensen S, Reed SI . 2001 Nat. Cell Biol. 3: 619–627
Cohen-Fix O, Koshland D . 1997 Proc. Natl. Acad. Sci. USA 94: 14361–14366
Connor F, Bertwistle D, Mee PJ, Ross GM, Swift S, Grigorieva E, Tybulewicz VL, Ashworth A . 1997 Nat. Genet. 17: 423–430
Cortez D, Wang Y, Qin J, Elledge SJ . 1999 Science 286: 1162–1166
Deng CX . 2001 Mutat. Res. 477: 183–189
Deng CX . 2002 Environ. Mol. Mutagen. 39: 171–177
Deng CX, Brodie SG . 2000 Bioessays 22: 728–737
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CAJ, Butel JS, Bradley A . 1992 Nature 356: 215–221
Donehower LA . 1997 Cancer Surv. 29: 329–352
Elson A, Wang Y, Daugherty CJ, Morton CC, Zhou F, Campos-Torres J, Leder P . 1996 Proc. Natl. Acad. Sci. USA 93: 13084–13089
Ferguson DO, Alt FW . 2001 Oncogene 20: 5572–5579
Fornace Jr AJ, Nebert DW, Hollander MC, Luethy JD, Papathanasiou M, Fargnoli J, Holbrook NJ . 1989 Mol. Cell. Biol. 9: 4196–4203
Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande WGF . 1996 Science 271: 1744–1747
Gallant P, Nigg EA . 1992 J. Cell. Biol. 117: 213–224
Ghadimi BM, Sackett DL, Difilippantonio MJ, Schrock E, Neumann T, Jauho A, Auer G, Ried T . 2000 Genes Chrom. Cancer 27: 183–190
Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA . 1999 Cell 97: 575–586
Hollander MC, Sheikh MS, Bulavin DV, Lundgren K, Augeri-Henmueller L, Shehee R, Molinaro TA, Kim KE, Tolosa E, Ashwell JD, Rosenberg MP, Zhan Q, Fernandez-Salguero PM, Morgan WF, Deng CX, Fornace Jr AJ . 1999 Nat. Genet. 23: 176–184
Hollander MC, Kovalsky O, Salvador JM, Kim KE, Patterson AD, Haines DC, Fornace Jr AJ . 2001 Cancer Res. 61: 2487–2491
Hollstein M, Sidransky D, Vogelstein B, Harris CC . 1991 Science 253: 49–53
Hsu LC, White RL . 1998 Proc. Natl. Acad. Sci. USA 95: 12983–12988
Jin S, Zhao H, Fan F, Blanck P, Fan W, Colchagie AB, Fornace Jr AJ, Zhan Q . 2000 Oncogene 19: 4050–4057
Kastan MB, Zhan Q, el-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B, Fornace Jr AJ . 1992 Cell 71: 587–597
Khanna KK, Jackson SP . 2001 Nat. Genet. 27: 247–254
Law W, Linial ML . 2001 Oncogene 20: 1118–1127
Leder A, Pattengale PK, Kuo A, Stewart TA, Leder P . 1986 Cell 45: 485–495
Leung CH, Lam W, Zhuang WJ, Wong NS, Yang MS, Fong WF . 2001 Biochem. Biophys. Res. Commun. 285: 283–288
Li Q, Dang CV . 1999 Mol. Cell. Biol. 19: 5339–5351
Liu Y, West SC . 2002 Breast Cancer Res. 4: 9–13
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD . 1992 Cell 70: 923–935
Lu YY, Lam CY, Yung BY . 1996 Biochem. J. 317: 321–327
MacLachlan TK, Dash BC, Dicker DT, El-Deiry WS . 2000 J. Biol. Chem. 275: 31869–31875
Mai S, Hanley-Hyde J, Fluri M . 1996 Oncogene 12: 277–288
Mallory JC, Petes TD . 2000 Proc. Natl. Acad. Sci. USA 97: 13749–13754
Marhin WW, Chen S, Facchini LM, Fornace Jr AJ, Penn LZ . 1997 Oncogene 14: 2825–2834
Moberg KH, Tyndall WA, Hall DJ . 1992 J. Cell. Biochem. 49: 208–215
Nicolaidis P, Petersen MB . 1998 Hum. Reprod. 13: 313–319
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K . 2000 Cell 103: 127–140
Oster SK, Ho CS, Soucie EL, Penn LZ . 2002 Adv. Cancer Res. 84: 81–154
Papathanasiou MA, Kerr NC, Robbins JH, McBride OW, Alamo IJ, Barrett SF, Hickson ID, Fornace AJJ . 1991 Mol. Cell. Biol. 11: 1009–1016
Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, Doxsey SJ . 1998 Cancer Res. 58: 3974–3985
Rodilla V . 1993 Mutat. Res. 300: 281–291
Shen SX, Weaver Z, Xu X, Li C, Weinstein M, Chen L, Guan XY, Ried T, Deng CX . 1998 Oncogene 17: 3115–3124
Shiloh Y . 2001 Biochem. Soc. Trans. 29: 661–666
Somasundaram K, MacLachlan TK, Burns TF, Sgagias M, Cowan KH, Weber BL, el-Deiry WS . 1999 Oncogene 18: 6605–6614
Spruck CH, Won KA, Reed SI . 1999 Nature 401: 297–300
Stumm M, Neubauer S, Keindorff S, Wegner RD, Wieacker P, Sauer R . 2001 Cytogenet. Cell. Genet. 92: 186–191
Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P . 1982 Proc. Natl. Acad. Sci. USA 79: 7837–7841
Tlsty TD . 1990 Proc. Natl. Acad. Sci. USA 87: 3132–3136
Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L, Hollander MC, O'Connor PM, Fornace Jr AJ, Harris CC . 1999 Proc. Natl. Acad. Sci. USA 96: 3706–3711
Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, Harris CC, Ried T, Deng CX . 1999 Mol. Cell. 3: 389–395
Yamamoto A, Guacci V, Koshland D . 1996 J. Cell. Biol. 133: 85–97
Yin XY, Grove L, Datta NS, Katula K, Long MW, Prochownik EV . 2001 Cancer Res. 61: 6487–6493
Zhan Q, Lord KA, Alamo IJ, Hollander MC, Carrier F, Ron D, Kohn KW, Hoffman B, Liebermann DA, Fornace Jr AJ . 1994 Mol. Cell. Biol. 14: 2361–2371
Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM, Fornace Jr AJ . 1996 DNA Cell Biol. 15: 805–815
Zhan Q, Chen IT, Antinore MJ, Fornace Jr AJ . 1998 Mol. Cell. Biol. 18: 2768–2778
Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC, Fornace Jr AJ . 1999 Oncogene 18: 2892–2900
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hollander, M., Fornace, A. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21, 6228–6233 (2002). https://doi.org/10.1038/sj.onc.1205774
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205774
Keywords
This article is cited by
-
Nuclear complement C3b promotes paclitaxel resistance by assembling the SIN3A/HDAC1/2 complex in non-small cell lung cancer
Cell Death & Disease (2023)
-
PPARγ regulates the expression of genes involved in the DNA damage response in an inflamed endometrium
Scientific Reports (2022)
-
A novel chalcone derivative suppresses melanoma cell growth through targeting Fyn/Stat3 pathway
Cancer Cell International (2020)
-
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
Journal of Experimental & Clinical Cancer Research (2019)
-
GADD45α sensitizes cervical cancer cells to radiotherapy via increasing cytoplasmic APE1 level
Cell Death & Disease (2018)